Most Anaphylaxis Patients in ER Treated Appropriately

Share this content:
Most Anaphylaxis Patients in ER Treated Appropriately
Most Anaphylaxis Patients in ER Treated Appropriately

WEDNESDAY, Oct. 12, 2016 (HealthDay News) -- The majority of anaphylaxis patients seeking treatment in Belgian emergency departments are treated in accordance with the European Academy of Allergy and Clinical Immunology (EAACI) guidelines, according to a study published Oct. 6 in Allergy.

Yora Mostmans, M.D., from Universitair Ziekenhuis Brussel, and colleagues analyzed patient data collected from April 2009 to April 2013 to determine how quickly patients presenting with anaphylaxis were treated in emergency departments and whether treatment followed the EAACI guidelines.

The researchers found that 0.04 percent of all emergency visits involved adults presenting with anaphylaxis. Nearly two-thirds (64 percent) of patients received their first medical help later than 30 minutes after symptom onset. Treatment included: adrenaline (67 percent), oral antihistamines (85 percent), and IV glucocorticosteroids (89 percent). Forty-six percent of patients were discharged directly from the emergency department, of whom 87 percent received further medical prescriptions and three-fourths were instructed to consult an allergist for adequate diagnosis. Fifty-four percent of patients were hospitalized.

"The majority of patients were treated according to the EAACI-guidelines for management of anaphylaxis, but only a minority received the recommended adrenaline auto-injector for self-administration at discharge," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »